A large pharmaceutical sponsor replaced monthly manual safety review with a daily, interactive process that surfaces signals while there is still time to act.
The sponsor ran a portfolio of trials in a serious disease area, where the safety profile of a candidate matters enormously. Safety data was reviewed once a month. A team worked through more than a thousand adverse events by hand, comparing the current cycle against earlier ones and looking for anything that stood out.
The process worked, but it was slow. By the time a possible signal was confirmed, three weeks could have passed since the underlying events were recorded. In a safety setting, that delay is uncomfortable. The team wanted to see issues sooner, and they wanted to spend their time on judgment rather than on assembling spreadsheets.
We worked with the safety physicians and the data team to understand how they actually reviewed a study, then built an interactive review application around that workflow rather than replacing it.
The application was built to the sponsor's standards and runs inside their validated environment, so the output carries the documentation a regulated process requires.
They understood our standards before they wrote a line of code. The review application changed how our safety meetings run.
Safety review shifted from a monthly event to a continuous one. Signals that once took three weeks to confirm are now visible within days, and the review meeting works from live data rather than a month-old extract. The team spends less time preparing material and more time assessing what it means.
Just as important, the move did not add risk. Because the application lives in a validated environment and traces every value back to its source, it stands up to the same scrutiny as the manual process it replaced.
We can show you what continuous, interactive review would look like for your studies.
Talk to our team